A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive
Clinical trial NCT04528719 · COMPLETED
Trial details
- NCT number
- NCT04528719
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2024-07-18
- Enrollment
- 651
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.